Paolo Barone Selected Research

Pramipexole (Mirapex)

1/2014	Minimal clinically important difference in Parkinson's disease as assessed in pivotal trials of pramipexole extended release.
8/2013	Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial.
1/2013	Compulsive drumming induced by dopamine agonists in Parkinson's disease: Another aspect of punding.
7/2012	Efficacy and safety of extended- versus immediate-release pramipexole in Japanese patients with advanced and L-dopa-undertreated Parkinson disease: a double-blind, randomized trial.
12/2010	Exercise dependence induced by pramipexole in Parkinson's Disease-a case report.
11/2010	Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease.
10/2010	Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease.
10/2010	Role of pramipexole in the management of Parkinson's disease.
8/2010	Rationale for delayed-start study of pramipexole in Parkinson's disease: the PROUD study.
6/2010	Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paolo Barone Research Topics

Disease

92	Parkinson Disease (Parkinson's Disease) 01/2022 - 07/2003
17	Parkinsonian Disorders (Parkinsonism) 01/2021 - 05/2002
14	Cognitive Dysfunction 01/2022 - 04/2009
11	Dementia (Dementias) 01/2021 - 06/2007
10	Multiple System Atrophy 01/2021 - 04/2005
7	Dyskinesias (Dyskinesia) 10/2021 - 05/2006
6	Movement Disorders (Movement Disorder) 01/2021 - 12/2007
5	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 08/2022 - 06/2014
5	Tremor (Tremors) 05/2022 - 08/2007
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 04/2005
4	Disease Progression 01/2021 - 10/2004
4	Aphasia (Dysphasia) 01/2021 - 08/2017
4	Pain (Aches) 11/2020 - 09/2008
4	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 01/2019 - 02/2011
4	Essential Tremor (Essential Tremors) 06/2011 - 07/2003
3	Orthostatic Hypotension (Postural Hypotension) 01/2021 - 08/2013
3	Dystonia (Limb Dystonia) 01/2019 - 05/2014
3	Nausea 06/2016 - 11/2010
3	Hallucinations (Hallucination) 08/2013 - 01/2009
2	Synucleinopathies 01/2022 - 01/2021
2	Alzheimer Disease (Alzheimer's Disease) 07/2017 - 01/2014
2	Sleepiness 06/2016 - 11/2010
2	CADASIL 01/2015 - 01/2015
2	Restless Legs Syndrome (Restless Legs) 10/2010 - 07/2004
2	Major Depressive Disorder (Major Depressive Disorders) 04/2009 - 01/2009
1	Ganglion Cysts (Ganglion) 08/2022
1	Paralysis (Palsy) 07/2022
1	Paresthesia (Dysesthesia) 07/2022
1	Channelopathies 01/2021
1	Familial paroxysmal dystonia 01/2021
1	Hearing Loss (Hearing Impairment) 01/2021
1	COVID-19 01/2021
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	Epilepsy (Aura) 01/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 11/2020
1	Hyponatremia 11/2020

Drug/Important Bio-Agent (IBA)

20	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 09/2003
18	Pharmaceutical PreparationsIBA 01/2022 - 02/2011
13	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2013
12	Pramipexole (Mirapex)FDA LinkGeneric 01/2014 - 05/2006
10	Dopamine Agonists (Dopamine Agonist)IBA 11/2020 - 05/2006
8	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2021 - 03/2004
6	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2019 - 03/2004
5	Dopamine (Intropin)FDA LinkGeneric 01/2019 - 02/2011
4	SandIBA 01/2021 - 08/2017
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 04/2009
4	Uric Acid (Urate)IBA 12/2016 - 07/2014
4	Arginine (L-Arginine)FDA Link 10/2010 - 04/2005
4	Growth Hormone (Somatotropin)IBA 01/2008 - 04/2005
3	Glucosylceramidase (Glucocerebrosidase)IBA 01/2021 - 01/2013
3	SynucleinsIBA 01/2021 - 10/2012
3	Antipsychotic Agents (Antipsychotics)IBA 11/2020 - 01/2002
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019 - 03/2017
3	synaptojaninIBA 01/2019 - 01/2017
3	Phosphotransferases (Kinase)IBA 01/2018 - 06/2007
3	Coffee FDA Link 10/2017 - 10/2010
3	Insulin-Like Growth Factor I (IGF-1)IBA 01/2017 - 11/2010
3	rasagiline (Azilect)FDA Link 02/2015 - 12/2011
2	safinamideIBA 01/2021 - 01/2017
2	Carbidopa (Lodosyn)FDA LinkGeneric 11/2020 - 07/2012
2	IronIBA 01/2019 - 07/2017
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019 - 01/2017
2	CopperIBA 01/2019 - 04/2009
2	Leucine (L-Leucine)FDA Link 01/2018 - 06/2007
2	AntioxidantsIBA 06/2016 - 06/2011
2	Nonsense Codon (Nonsense Mutation)IBA 01/2015 - 01/2015
2	SmokeIBA 01/2015 - 05/2014
2	Insulin (Novolin)FDA Link 06/2014 - 07/2013
2	Rivastigmine (Exelon)FDA LinkGeneric 01/2014 - 08/2008
2	alpha-SynucleinIBA 01/2013 - 07/2003
2	perampanelIBA 01/2012 - 05/2010
2	Cholinergic Agents (Cholinergics)IBA 10/2011 - 09/2009
2	Antidepressive Agents (Antidepressants)IBA 06/2010 - 05/2006
2	Apomorphine FDA Link 12/2007 - 05/2002
2	ropinirole (Requip)FDA LinkGeneric 03/2007 - 07/2004
2	Sertraline (Zoloft)FDA LinkGeneric 08/2006 - 05/2006
1	Retinaldehyde (Retinal)IBA 08/2022
1	COVID-19 VaccinesIBA 07/2022
1	ChAdOx1 nCoV-19IBA 07/2022
1	AlcoholsIBA 05/2022
1	GABA-A Receptors (GABA(A) Receptor)IBA 05/2022
1	Potassium Channels (Potassium Channel)IBA 05/2022
1	Vitamin D FDA LinkGeneric 11/2021
1	mRNA VaccinesIBA 10/2021
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2021
1	hydroxide ionIBA 01/2021
1	ioflupaneIBA 01/2021
1	human PRRT2 proteinIBA 01/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021
1	Ion Channels (Ion Channel)IBA 01/2021
1	Serotonin (5 Hydroxytryptamine)IBA 01/2019

Therapy/Procedure

13	Therapeutics 01/2019 - 03/2007
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2002
3	Activities of Daily Living (ADL) 01/2014 - 02/2006
2	Deep Brain Stimulation 05/2022 - 12/2007
1	Nutritional Support (Artificial Feeding) 05/2022
1	Physical Therapy Modalities (Physical Therapy Technique) 05/2022
1	Autonomic Denervation 01/2021
1	Hearing Aids (Hearing Aid) 01/2021